CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders

β-amyloid (Aβ) plaque accumulation is a hallmark of Alzheimer's disease (AD). It is believed to start many years prior to symptoms and is reflected by reduced cerebrospinal fluid (CSF) levels of the peptide Aβ1–42 (Aβ42). Here we tested the hypothesis that baseline levels of CSF proteins involv...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mattsson, N, Insel, P, Nosheny, R, Zetterberg, H, Trojanowski, J Q, Shaw, L M, Tosun, D, Weiner, M
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2013
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3756294/
https://ncbi.nlm.nih.gov/pubmed/23962923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2013.69
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items